⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Fresenius Kabi USA, LLC: Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi

DrugsSource: FDA (drug) · Date: 2026-07-29

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Fresenius Kabi

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
Fresenius Kabi USA, LLC
Product
Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-578-05; NDC Vial: 63323-578-07
Reason / hazard
Presence of Particulate Matter: Hair was found in product
Classification
Class II
Status
Ongoing
Distribution / sold at
Nationwide within in the USA
Recall initiated
2026-07-16
Code info
Lot #: 6134349, 6134620 Exp. Date 11/2026
Product quantity
59,425 vials
Voluntary mandated
Voluntary: Firm initiated
City
Lake Zurich
State
IL
Country
United States
Event id
99449
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.